Company profile
MindWalk Holdings Corp.
NASDAQ: HYFT · Healthcare · Biotechnology
Canadian filerHQ Victoria, BCCIK 0001715925Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 66
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, listing tenure · ↓ return on equity, return on assets
Methodology →Revenue TTM
$13.1M
Rev growth YoY (TTM)
+2.1%
Net income (FY)
-$21.7M
Employees
76
as of 2026-08-19
Market cap
$62.5M
as of 2026-08-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$21.7M-30.2M CAD2025
Total assets$32.2M44.4M CAD2025
Liabilities$15.1M20.8M CAD2025
Revenue by segment
Filed disclosures · FY2025
By product
Project Revenue91%
Product Sales9%
By geography
UNITED STATES51%
Europe42%
AUSTRALIA4%
All Other Countries2%
CANADA1%
The read
What is MindWalk Holdings Corp.’s financial profile?
MindWalk Holdings Corp. earned -$21.7M in FY2025 net income.
Peers · Healthcare
OS Therapies Incorporated——Citius Oncology, Inc.——Boundless Bio, Inc.——MiNK Therapeutics, Inc.——BioStem Technologies, Inc.——Apollomics, Inc.——Key facts
CEOJennifer Lynne Bath
SectorHealthcare
IndustryBiotechnology
HeadquartersVictoria, BC
ExchangeNASDAQ: HYFT
Employees76
IPO date2002-01-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.